Industry

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities In Nanocellulose, Nano-Based Delivery Systems And Recycling Technologies” report has been added to ResearchAndMarkets.com’s offering. This issue of the Nanotechnology Opportunity Engine captures innovations related to the use of nanotechnology for effective drug delivery such as the use of nanoparticles, microneedles, and nanoemulsions along with capturing technology developments related to battery … [Read more…]

The dataset will be publicly available for a Kaggle competition presented at NeurIPS 2022 hosted by Open Problems in Single-Cell Analysis in collaboration with Chan Zuckerberg Initiative, Chan Zuckerberg Biohub, Yale University, and Helmholtz Munich SOMERVILLE, Mass.–(BUSINESS WIRE)–Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today … [Read more…]

 Achievement caps a banner year for the company and health system specialty pharmacy growth ATLANTA–(BUSINESS WIRE)–#healthsystems—Trellis Rx, LLC, a leading health system specialty pharmacy services provider now part of the CPS Solutions, LLC, family of companies, has been named to the prestigious Inc. 5000 list for the second consecutive year, ranking #754. The recognition, which … [Read more…]

Now over 1 in 5 Thoracic Organ Transplants are preserved using Paragonix Advanced Organ Preservation and Tracking Technology CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. is announcing a major milestone of preserving over 2,000 donor organs, providing transplant centers Advanced Organ Preservation (AOPT) technology and a nationwide clinical support network. Each of these technologies utilize first-of-its-kind preservation … [Read more…]

System-Wide Sales Up 84% YoY, Delivered One Million Wellness Services and Introduces Medical Advisory Board as it Continues Exponential Growth AUSTIN, Texas–(BUSINESS WIRE)–Restore Hyper Wellness (Restore), the leading provider of proactive wellness services, announced its business performance results for the first half of 2022, with system-wide sales surpassing $60 million, an increase of 84% year-over-year. … [Read more…]

Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties SAN FRANCISCO–(BUSINESS WIRE)–#AI–Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet® platform for … [Read more…]

Selected for National Institute of Health (NIH) I-RED Award to expand support for academic innovation, translation, and commercialization LOUISVILLE, Ky.–(BUSINESS WIRE)–XLerateHealth (XLH), a national healthcare accelerator based in Louisville, KY, in partnership with the University of Kentucky (UK) through UK Innovate, has been awarded the first phase of a potential $3.25M multi-year grant by the … [Read more…]

Max Krakowiak appointed new chief financial officer, replacing Jamey Mock WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Senior Vice President and Chief Financial Officer Jamey Mock will be transitioning from the Company to pursue an outside opportunity. The Company’s Board of Directors has unanimously … [Read more…]

Agilent will supply analytical and preparative chromatography equipment for Mytide’s discovery and personalized therapeutics technology platform. Agreement aligns with Mytide’s focus on bringing together technology companies to address automation, reliability and data quality issues across the peptide industry. BOSTON–(BUSINESS WIRE)–Mytide Therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has partnered with … [Read more…]

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, and its partner Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced that the U.S. Drug Enforcement Agency (“DEA”) has granted a Schedule … [Read more…]